Explore

Discover daily Discover daily
How Peptides Aim at Disease With Unusual Precision

How Peptides Aim at Disease With Unusual Precision

Peptides have emerged as a significant class of compounds in the field of medicine, offering promising therapeutic potential. These short chains of...
Trendline Trendline
Epicrispr Biotechnologies Partners with Forge Biologics for Gene Therapy Trials in FSHD

Epicrispr Biotechnologies Partners with Forge Biologics for Gene Therapy Trials in FSHD

Epicrispr Biotechnologies Partners with Forge Biologics for Gene Therapy Trials in FSHD
Trendline Trendline
Epicrispr and Forge Biologics Partner for AAV Development and Manufacturing

Epicrispr and Forge Biologics Partner for AAV Development and Manufacturing

Epicrispr and Forge Biologics Partner for AAV Development and Manufacturing
Trendline Trendline
Ascletis Pharma to Present Innovative Obesity Treatment Data at European Congress

Ascletis Pharma to Present Innovative Obesity Treatment Data at European Congress

Ascletis Pharma to Present Innovative Obesity Treatment Data at European Congress
Trendline Trendline
GSK Licenses siRNA Drug from China's SiranBio in $1 Billion Deal to Target Cardiometabolic Diseases

GSK Licenses siRNA Drug from China's SiranBio in $1 Billion Deal to Target Cardiometabolic Diseases

GSK Licenses siRNA Drug from China's SiranBio in $1 Billion Deal to Target Cardiometabolic Diseases
Trendline Trendline
NImmune Biopharma Presents Promising Data for IBD Treatment at Digestive Disease Week

NImmune Biopharma Presents Promising Data for IBD Treatment at Digestive Disease Week

NImmune Biopharma Presents Promising Data for IBD Treatment at Digestive Disease Week
Trendline Trendline
Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks

Pharmaceutical Leaders Utilize Protein Biomarkers to Mitigate Drug Development Risks
Trendline Trendline
Lunai Bioworks Secures $20 Million to Enhance CNS Drug Delivery and Neurotherapeutic IP

Lunai Bioworks Secures $20 Million to Enhance CNS Drug Delivery and Neurotherapeutic IP

Lunai Bioworks Secures $20 Million to Enhance CNS Drug Delivery and Neurotherapeutic IP
Trendline Trendline
Mapi Pharma Plans U.S. Aseptic Manufacturing Facility to Meet Growing Demand for Injectables

Mapi Pharma Plans U.S. Aseptic Manufacturing Facility to Meet Growing Demand for Injectables

Mapi Pharma Plans U.S. Aseptic Manufacturing Facility to Meet Growing Demand for Injectables
Trendline Trendline
Vertex Pharmaceuticals Prepares for Potential Breakthrough in Renal Treatment with Povetacicept

Vertex Pharmaceuticals Prepares for Potential Breakthrough in Renal Treatment with Povetacicept

Vertex Pharmaceuticals Prepares for Potential Breakthrough in Renal Treatment with Povetacicept
Trendline Trendline
Lunai Bioworks Secures $20 Million to Enhance CNS Drug Delivery and Neurotherapeutics

Lunai Bioworks Secures $20 Million to Enhance CNS Drug Delivery and Neurotherapeutics

Lunai Bioworks Secures $20 Million to Enhance CNS Drug Delivery and Neurotherapeutics
Trendline Trendline
Arrowhead Pharmaceuticals Licenses RNAi Therapeutic for MASH to Madrigal Pharmaceuticals

Arrowhead Pharmaceuticals Licenses RNAi Therapeutic for MASH to Madrigal Pharmaceuticals

Arrowhead Pharmaceuticals Licenses RNAi Therapeutic for MASH to Madrigal Pharmaceuticals